SB756050
目录号: A12759
TGR5 激动剂
SB756050 是一种选择性的 TGR5 激动剂,目前正在进行第一阶段临床试验,用于治疗 2型糖尿病。
Discription | SB756050 is a selective TGR5 agonist currently in phase 1clinical trials for the treatment of type 2 diabetes. |
---|
目录号 | A12759 |
---|---|
分子式 | C21H28N2O8S2 |
分子量 | 500.59 |
CAS号 | 447410-57-3 |
SMILES | O=S(N1CCN(S(=O)(C2=CC=C(OC)C(OC)=C2)=O)CCC1)(C3=CC=C(OC)C(OC)=C3)=O |
其他名称 | SB-756050; SB 756050 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 91 mg/mL (181.78 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.98 mL | 99.88 mL | 199.76 mL |
0.5 mM | 4 mL | 19.98 mL | 39.95 mL |
1 mM | 2 mL | 9.99 mL | 19.98 mL |
5 mM | 0.4 mL | 2 mL | 4 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2